US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.8832
- -0.0220-2.43%
Close Dec 4 16:00 ET
- 0.8900
- +0.0068+0.77%
Post 19:51 ET
257.29MMarket Cap-4648P/E (TTM)
0.9265High0.8800Low4.10MVolume0.9169Open0.9052Pre Close3.69MTurnover1.43%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High6.35P/B253.78MFloat Cap0.360052wk Low--Dividend TTM287.34MShs Float778.1999Historical High--Div YieldTTM5.14%Amplitude0.1700Historical Low0.8990Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ocugen Stock Forum
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet